Xontogeny Overview
- Investor Type
-
Accelerator/Incubator
- Status
-
Active
- Professionals
-
5
- Investments
-
39
- Portfolio
-
16
- Exits
-
17
Xontogeny General Information
Company Description
Founded in 2016, Xontogeny is an accelerator firm based in Boston, Massachusetts. The firm prefers to invest in the healthcare and life science sectors.
Business Details
Website
www.xontogeny.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 361 Newbury Street
- Suite 501
- Boston, MA 02115
- United States
Xontogeny Investments (39)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Delve Bio | 11-Sep-2026 | Early Stage VC | Biotechnology | Generating Revenue | ||
| Crystalys Therapeutics | 30-Sep-2025 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Mercy BioAnalytics | 28-Aug-2025 | Decision/Risk Analysis | Generating Revenue | |||
| Avalyn Pharma | 22-Jul-2025 | Drug Discovery | Generating Revenue | |||
| Galvanize Therapeutics | 07-Jul-2025 | Therapeutic Devices | Generating Revenue | |||
| CereVasc | 10-May-2024 | Therapeutic Devices | Generating Revenue | |||
| Adaptilens | 02-May-2024 | Therapeutic Devices | Pre-Clinical Trials | |||
| Neurosterix | 02-Apr-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Marea | 01-Jan-2024 | Early Stage VC | Biotechnology | Clinical Trials - Phase 2 | ||
| Avalyn Pharma | 22-Sep-2023 | Later Stage VC | Drug Discovery | Generating Revenue |
Xontogeny Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| PolyCore Therapeutics | 06-Oct-2026 | Out of Business | |
| Marea | 17-Sep-2026 | ||
| Nephraegis Therapeutics | 10-May-2026 | ||
| Avalyn Pharma | 30-Apr-2026 | ||
| AsclepiX Therapeutics | 26-Apr-2026 | ||
| Astria Therapeutics | 23-Jan-2026 | ||
| Halozyme Surf Bio | 22-Dec-2025 | ||
| Ceptur Therapeutics | 12-Nov-2025 | ||
| Cargo Therapeutics | 18-Aug-2025 | Merger/Acquisition | |
| Avenge Bio | 01-Aug-2024 | Out of Business |
Xontogeny Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Xontogeny Co-Investors (94)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Perceptive Advisors | 14 |
|
|
||
| Janus Henderson Investors |
|
|
|||
| T. Rowe Price Group |
|
|
|||
| Wellington Management |
|
|
|||
| Piper Sandler |
|
|
Xontogeny FAQs
-
What is Xontogeny?
Founded in 2016, Xontogeny is an accelerator firm based in Boston, Massachusetts.
-
When was Xontogeny founded?
Xontogeny was founded in 2016.
-
Where is Xontogeny headquartered?
Xontogeny is headquartered in Boston, MA.
-
What is Xontogeny's total asset value?
Xontogeny has around in total assets under management.
-
How many investments has Xontogeny made?
Xontogeny has made 39 investments.
-
What has Xontogeny invested in?
Xontogeny has made numerous investments in companies like Delve Bio, Crystalys Therapeutics, and Mercy BioAnalytics within the Biotechnology, Drug Discovery, and Decision/Risk Analysis industries.
-
What has Xontogeny invested in recently?
Xontogeny's latest investment was on 11-Sep-2026 in Delve Bio, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
